These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
380 related articles for article (PubMed ID: 11986090)
1. Ocular toxoplasmosis: clinical features and prognosis of 154 patients. Bosch-Driessen LE; Berendschot TT; Ongkosuwito JV; Rothova A Ophthalmology; 2002 May; 109(5):869-78. PubMed ID: 11986090 [TBL] [Abstract][Full Text] [Related]
2. Active ocular toxoplasmosis in Turkish patients: a report on 109 cases. Tugal-Tutkun I; Corum I; Otük B; Urgancioglu M Int Ophthalmol; 2005 Dec; 26(6):221-8. PubMed ID: 17318320 [TBL] [Abstract][Full Text] [Related]
3. Recurrent ocular disease in postnatally acquired toxoplasmosis. Bosch-Driessen EH; Rothova A Am J Ophthalmol; 1999 Oct; 128(4):421-5. PubMed ID: 10577582 [TBL] [Abstract][Full Text] [Related]
4. Vitreal, retinal, and choroidal findings in active and scarred toxoplasmosis lesions: a prospective study by spectral-domain optical coherence tomography. Goldenberg D; Goldstein M; Loewenstein A; Habot-Wilner Z Graefes Arch Clin Exp Ophthalmol; 2013 Aug; 251(8):2037-45. PubMed ID: 23568271 [TBL] [Abstract][Full Text] [Related]
5. Monitoring of visual field over 6 months after active ocular toxoplasmosis. Blot J; Aptel F; Chumpitazi BFF; Gain P; Vasseneix C; Savy O; Bouillet L; Pelloux H; Chiquet C Graefes Arch Clin Exp Ophthalmol; 2019 Jul; 257(7):1481-1488. PubMed ID: 31037491 [TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics, visual acuity outcomes, and factors associated with loss of vision among patients with active ocular toxoplasmosis: A retrospective study in a Thai tertiary center. Sittivarakul W; Treerutpun W; Tungsattayathitthan U PLoS Negl Trop Dis; 2024 Jun; 18(6):e0012232. PubMed ID: 38843299 [TBL] [Abstract][Full Text] [Related]
8. Risk factors for recurrences and visual impairment in patients with ocular toxoplasmosis: A systematic review and meta-analysis. Cifuentes-González C; Rojas-Carabali W; Pérez ÁO; Carvalho É; Valenzuela F; Miguel-Escuder L; Ormaechea MS; Heredia M; Baquero-Ospina P; Adan A; Curi A; Schlaen A; Urzua CA; Couto C; Arellanes L; de-la-Torre A PLoS One; 2023; 18(4):e0283845. PubMed ID: 37011101 [TBL] [Abstract][Full Text] [Related]
9. Longitudinal study of new eye lesions in treated congenital toxoplasmosis. Phan L; Kasza K; Jalbrzikowski J; Noble AG; Latkany P; Kuo A; Mieler W; Meyers S; Rabiah P; Boyer K; Swisher C; Mets M; Roizen N; Cezar S; Remington J; Meier P; McLeod R; Ophthalmology; 2008 Mar; 115(3):553-559.e8. PubMed ID: 17825418 [TBL] [Abstract][Full Text] [Related]
11. Toxoplasmic retinochoroiditis in an Italian referral center. Accorinti M; Bruscolini A; Pirraglia MP; Liverani M; Caggiano C Eur J Ophthalmol; 2009; 19(5):824-30. PubMed ID: 19787604 [TBL] [Abstract][Full Text] [Related]
17. [Extensive toxoplasmic retinochoroiditis. Diagnostic and therapeutic management]. Theaudin M; Bodaghi B; Cassoux N; Romand S; Le Mer Y; Lemaitre C; Fardeau C; Thulliez P; LeHoang P J Fr Ophtalmol; 2003 Nov; 26(9):921-7. PubMed ID: 14631276 [TBL] [Abstract][Full Text] [Related]
18. Time patterns of recurrences and factors predisposing for a higher risk of recurrence of ocular toxoplasmosis. Reich M; Ruppenstein M; Becker MD; Mackensen F Retina; 2015 Apr; 35(4):809-19. PubMed ID: 25299969 [TBL] [Abstract][Full Text] [Related]
19. Ocular toxoplasmosis after the fifth decade. Labalette P; Delhaes L; Margaron F; Fortier B; Rouland JF Am J Ophthalmol; 2002 Apr; 133(4):506-15. PubMed ID: 11931784 [TBL] [Abstract][Full Text] [Related]
20. Ocular manifestations of HIV infection. Jabs DA Trans Am Ophthalmol Soc; 1995; 93():623-83. PubMed ID: 8719695 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]